Skip to main content
TipRanks
Go Ultimate75% OFF

Harbor BioSciences (HRBR) Ratios

19 Followers

Harbor BioSciences Ratios

HRBR's free cash flow for Q4 2025 was $-14.21M. For the 2025 fiscal year, HRBR's free cash flow was decreased by $-1.46M and operating cash flow was $-12.75M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio0.00―4.403.882.16
Quick Ratio0.00―4.243.812.10
Cash Ratio0.00―0.720.500.41
Solvency Ratio0.00―0.160.470.66
Operating Cash Flow Ratio-2.61―-0.410.681.05
Short-Term Operating Cash Flow Coverage-50.08―0.004.928.54
Net Current Asset Value$ -6.22M―$ 68.00M$ 118.02M$ 13.66M
Leverage Ratios
Debt-to-Assets Ratio0.00―0.050.200.22
Debt-to-Equity Ratio0.01―0.070.310.40
Debt-to-Capital Ratio0.01―0.060.240.29
Long-Term Debt-to-Capital Ratio0.00―0.020.220.23
Financial Leverage Ratio0.00―1.341.571.83
Debt Service Coverage Ratio0.00―636.877.3410.11
Interest Coverage Ratio0.00―-2458.0718622.00124.17
Debt to Market Cap0.01―0.050.800.69
Interest Debt Per Share0.02―0.281.651.63
Net Debt to EBITDA0.00―-1.380.520.35
Profitability Margins
Gross Profit Margin0.00%―-7.79%25.23%26.17%
EBIT Margin0.00%―-9.71%19.89%48.02%
EBITDA Margin0.00%―3.11%29.26%58.75%
Operating Profit Margin0.00%―-18.51%19.89%42.48%
Pretax Profit Margin0.00%―-9.71%19.26%47.68%
Net Profit Margin0.00%―-8.02%13.92%37.41%
Continuous Operations Profit Margin0.00%―-8.02%13.92%37.41%
Net Income Per EBT100.00%―82.61%72.29%78.47%
EBT Per EBIT0.00%―52.48%96.84%112.25%
Return on Assets (ROA)0.00%―-6.76%10.22%23.19%
Return on Equity (ROE)0.02%―-9.05%16.00%42.34%
Return on Capital Employed (ROCE)0.00%―-17.78%17.65%34.00%
Return on Invested Capital (ROIC)0.00%―-14.34%12.21%25.35%
Return on Tangible Assets0.00%―-6.92%10.36%23.50%
Earnings Yield0.03%―-17.79%39.61%82.77%
Efficiency Ratios
Receivables Turnover0.00―31.4024.6033.36
Payables Turnover0.00―17.3410.419.11
Inventory Turnover0.00―44.6445.8635.15
Fixed Asset Turnover0.00―2.312.431.73
Asset Turnover0.00―0.840.730.62
Working Capital Turnover Ratio0.00―1.381.912.73
Cash Conversion Cycle0.00―-1.25-12.25-18.73
Days of Sales Outstanding0.00―11.6314.8410.94
Days of Inventory Outstanding0.00―8.187.9610.38
Days of Payables Outstanding0.00―21.0535.0540.06
Operating Cycle0.00―19.8022.8021.33
Cash Flow Ratios
Operating Cash Flow Per Share-0.55―-0.270.971.73
Free Cash Flow Per Share-0.55―-0.370.851.67
Dividend Paid and CapEx Coverage Ratio0.00―-2.077.1421.27
Capital Expenditure Coverage Ratio0.00―-2.688.1725.90
Operating Cash Flow Coverage Ratio-24.73―-0.980.591.07
Operating Cash Flow to Sales Ratio0.00―-0.060.160.38
Free Cash Flow Yield-33.50%―-18.38%40.02%80.94%
Valuation Ratios
Price-to-Earnings (P/E) Ratio3300.00―-5.232.571.22
Price-to-Sales (P/S) Ratio0.00―0.450.350.45
Price-to-Book (P/B) Ratio0.61―0.510.400.51
Price-to-Free Cash Flow (P/FCF) Ratio-2.99―-5.442.501.24
Price-to-Operating Cash Flow Ratio-2.99―-7.472.191.19
Price-to-Earnings Growth (PEG) Ratio-32.95―0.04-0.050.01
Enterprise Value Multiple0.00―13.141.731.12
Enterprise Value97.72M―81.30M141.85M162.58M
EV to EBITDA0.00―13.141.731.12
EV to Sales0.00―0.410.510.66
EV to Free Cash Flow-3.03―-4.923.591.79
EV to Operating Cash Flow-3.03―-6.763.151.73
Tangible Book Value Per Share-0.11―3.895.163.93
Shareholders’ Equity Per Share2.72―4.015.274.03
Tax and Other Ratios
Effective Tax Rate0.00―0.170.280.22
Revenue Per Share0.00―4.526.064.56
Net Income Per Share0.00―-0.360.841.71
Tax Burden1.00―0.830.720.78
Interest Burden0.00―1.000.970.99
Research & Development to Revenue0.00―0.000.000.00
SG&A to Revenue0.00―0.000.020.02
Stock-Based Compensation to Revenue0.00―0.000.000.00
Income Quality-1076.63―0.751.151.02

Currency in USD